Brief: Strides Pharma Science To Consider Fund Raise Via Non-Convertible Debentures
20/07/2022 14:22
July 20 (Reuters) - Strides Pharma Science Ltd SRID.NS :
* STRIDES PHARMA SCIENCE LTD - TO CONSIDER FUND RAISE VIA NON-CONVERTIBLE DEBENTURES
* STRIDES PHARMA SCIENCE LTD - TO CONSIDER FUND RAISE ON PRIVATE PLACEMENT BASIS
Source text for Eikon: ID:nBSE9zGxgx
Further company coverage: SRID.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees